Related Experiment Video
Updated: Jan 15, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.6K
Understanding the burden of ANCA-associated vasculitis
1Klinik für Innere Medizin, Rheumatologie, Pneumologie, Nephrologie und Diabetologie, Medius KLINIKEN Kirchheim-Teck & Nürtingen, Akademisches Lehrkrankenhaus der Universität Tübingen, Kirchheim unter Teck, Germany.
Rheumatology (Oxford, England)
|October 6, 2025
Summary
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a chronic autoimmune disease. This review explores AAV disease burden and strategies to improve patient quality of life.
Area of Science:
- Immunology
- Rheumatology
- Systemic Autoimmune Diseases
Background:
- Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a relapsing systemic autoimmune disorder.
- Characterized by organ damage and comorbidities from chronic inflammation.
- Despite improved remission and survival rates with immunosuppression, mortality remains high.
Purpose of the Study:
- To investigate key contributors to disease burden in AAV patients.
- To describe strategies for improving health-related quality of life in AAV.
Main Methods:
- Literature review of immunosuppression-based therapies for AAV.
- Analysis of treatment-related comorbidities, organ damage, and adverse effects.
- Exploration of factors impacting quality of life in AAV.
Main Results:
- Immunosuppression improves remission and survival but has significant side effects.
- Infections and treatment comorbidities are major concerns.
- Disease burden significantly impacts patient quality of life.
Conclusions:
- Managing AAV requires balancing treatment efficacy with adverse effects.
- Strategies to mitigate disease burden are crucial for improving patient outcomes.
- Further research needed to enhance long-term quality of life for AAV patients.
Related Concept Videos
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
465
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
465
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
293
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
293
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:26Nephrotic Syndrome II : Assessment and Medical Management
200
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
200
01:23Atherosclerosis IV: Nursing Management
363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
01:23Rheumatic Heart Disease I: Introduction
433
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
433